Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPLN
1101
Openlane
OPLN
$4.34B
| $16.8M | 0.01% |
770,800
-647,400
| -46% | -$14.8M |
|
|
MSGN
1102
DELISTED
MSG Networks Inc.
MSGN
| $16.8M | 0.01% |
964,200
+237,300
| +33% | +$3.95M |
|
|
ADVM
1103
DELISTED
Adverum Biotechnologies
ADVM
| $16.8M | 0.01% |
145,585
-123,715
| -46% | -$10.9M |
|
|
DFS
1104
DELISTED
Discover Financial Services
DFS
| $16.8M | 0.01% |
197,700
-355,900
| -64% | -$29.4M |
|
1105
IMAX
IMAX
$2.81B
| $16.7M | 0.01% |
818,800
+101,300
| +14% | +$2.16M |
|
1106
Regional Management Corp
RM
$297M
| $16.7M | 0.01% |
556,437
+15,200
| +3% | +$461K |
|
|
BRG
1107
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $16.7M | 0.01% |
1,383,963
+222,902
| +19% | +$2.66M |
|
|
EQC
1108
DELISTED
Equity Commonwealth
EQC
| $16.6M | 0.01% |
506,009
-788,151
| -61% | -$25.3M |
|
1109
Allot
ALLT
$377M
| $16.6M | 0.01% |
1,953,163
+151,537
| +8% | +$1.24M |
|
1110
Blue Bird Corp
BLBD
$2.04B
| $16.6M | 0.01% |
724,004
+228,404
| +46% | +$4.56M |
|
1111
Mondelez International
MDLZ
$79.4B
| $16.6M | 0.01% |
301,208
-3,902,547
| -93% | -$209M |
|
1112
First Commonwealth Financial
FCF
$2.18B
| $16.6M | 0.01% |
1,141,900
-210,700
| -16% | -$2.96M |
|
|
BBT
1113
Beacon Financial Corp
BBT
$2.71B
| $16.6M | 0.01% |
503,879
+27,356
| +6% | +$858K |
|
1114
HealthStream
HSTM
$849M
| $16.5M | 0.01% |
607,900
+600
| +0.1% | +$16.5K |
|
|
LTM
1115
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $16.5M | 0.01% |
1,625,190
+312,200
| +24% | +$3.49M |
|
|
NBIS
1116
Nebius Group N.V.
NBIS
$69.3B
| $16.5M | 0.01% |
+379,581
| New | +$14.2M |
|
1117
Euronet Worldwide
EEFT
$2.78B
| $16.5M | 0.01% |
104,645
+79,900
| +323% | +$12.1M |
|
1118
Mesa Laboratories
MLAB
$631M
| $16.4M | 0.01% |
65,900
-14,600
| -18% | -$3.42M |
|
1119
ANI Pharmaceuticals
ANIP
$1.72B
| $16.4M | 0.01% |
265,900
-67,300
| -20% | -$4.46M |
|
1120
Old Second Bancorp
OSBC
$1.31B
| $16.4M | 0.01% |
1,215,329
+35,904
| +3% | +$448K |
|
1121
Allstate
ALL
$64.7B
| $16.3M | 0.01% |
145,300
-842,800
| -85% | -$92M |
|
|
LTRPA
1122
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $16.3M | 0.01% |
2,222,321
+465,600
| +27% | +$3.75M |
|
|
EIGI
1123
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $16.3M | 0.01% |
3,474,100
+203,100
| +6% | +$834K |
|
|
FFIC
1124
DELISTED
Flushing Financial
FFIC
| $16.2M | 0.01% |
751,360
+121,000
| +19% | +$2.57M |
|
1125
Ryman Hospitality Properties
RHP
$7.82B
| $16.2M | 0.01% |
186,737
-112,363
| -38% | -$9.66M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.